Opioid Coprescribing with Sedatives after Implant-Based Breast Reconstruction.

ABSTRACT:

Background

Skeletal muscle relaxants and benzodiazepines are thought to mitigate against postoperative muscle contraction. The Centers for Disease Control and Prevention and the Food and Drug Administration warn against coprescribing them with opioids because of increased risks of overdose and death. The authors evaluated the frequency of coprescribing of opioids with skeletal muscle relaxants or benzodiazepines after implant-based reconstruction.

Methods

The authors examined health care claims to identify women (18 to 64 years old) who underwent implant-based breast reconstruction between January of 2008 and June of 2019 to determine the frequency of coprescribing, factors associated with coprescribing opioids and skeletal muscle relaxants or benzodiazepines, and the impact

SUBMITTER: Santosa KB 

PROVIDER: S-EPMC9712174 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature